Standardization has become an essential requirement in flow cytometry analysis.
In this publication, a highly standardized protocol – based on LyotubeTM reagents and application settings – has been applied to a multicentre study for the evaluation of Circulating Endothelial Cells (CECs).
Under physiological conditions, CECs are among the rarest populations of cells present in peripheral blood. They are considered potential biomarkers in many pathological settings that have an impact on vessel integrity and physiology, as well as in potentially vessel-damaging pharmacological treatments like chemotherapy.
Here, CEC physiological ranges and biological variability have been described in a cohort of 269 healthy volunteers, offering a valuable starting point for more robust clinical studies.
For more information about LyotubeTM reagents contact Gemma Coma Gemma.COMA@bd.com
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
©2018 BD. BD, the BD logo and all other trademarks are the property of Becton, Dickinson and Company.